临床相关细菌的抗菌耐药性与抗菌治疗
Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria.
作者信息
Meletis Georgios, Skoura Lemonia, Protonotariou Efthymia
机构信息
Department of Microbiology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, S. Kiriakidi Str. 1, 54636 Thessaloniki, Greece.
出版信息
Antibiotics (Basel). 2024 Jul 25;13(8):691. doi: 10.3390/antibiotics13080691.
Abstract
Antimicrobial resistance is a major public health problem, and the World Health Organization (WHO) has warned that the current antibiotic armamentarium is not sufficient to face future challenges [...].
摘要
抗菌药物耐药性是一个重大的公共卫生问题，世界卫生组织（WHO）已警告称，目前的抗生素储备不足以应对未来的挑战[……]
相似文献
1
Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria.临床相关细菌的抗菌耐药性与抗菌治疗
Antibiotics (Basel). 2024 Jul 25;13(8):691. doi: 10.3390/antibiotics13080691.
2
Antimicrobial Resistance (AMR).抗微生物药物耐药性（AMR）。
Br J Biomed Sci. 2023 Jun 28;80:11387. doi: 10.3389/bjbs.2023.11387. eCollection 2023.
3
The challenges of multi-drug-resistance in hepatology.肝医学领域的多药耐药挑战。
J Hepatol. 2016 Nov;65(5):1043-1054. doi: 10.1016/j.jhep.2016.08.006. Epub 2016 Aug 17.
4
Integrating human and environmental health in antibiotic risk assessment: A critical analysis of protection goals, species sensitivity and antimicrobial resistance.将人类健康和环境健康纳入抗生素风险评估：保护目标、物种敏感性和抗微生物药物耐药性的批判性分析。
Environ Int. 2017 Dec;109:155-169. doi: 10.1016/j.envint.2017.09.013. Epub 2017 Sep 28.
5
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines.应对撒哈拉以南非洲的抗菌药物耐药性：实施新的以人为本的世卫组织指南所面临的挑战和机遇。
Expert Rev Anti Infect Ther. 2024 Jun;22(6):379-386. doi: 10.1080/14787210.2024.2362270. Epub 2024 Jun 3.
6
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.抗生素耐药菌：现状与治疗选择，以加速新抗菌药物的研发。
Expert Rev Anti Infect Ther. 2022 Aug;20(8):1095-1108. doi: 10.1080/14787210.2022.2078308. Epub 2022 May 31.
7
Current status of countermeasures for infectious diseases and resistant microbes in the field of urology.泌尿外科领域传染病及耐药微生物的应对现状
Int J Urol. 2019 Dec;26(12):1090-1098. doi: 10.1111/iju.14087. Epub 2019 Aug 5.
8
Development of Antimicrobial Therapy Methods to Overcome the Antibiotic Resistance of Acinetobacter baumannii.克服鲍曼不动杆菌抗生素耐药性的抗菌治疗方法的研发
Acta Naturae. 2020 Jul-Sep;12(3):34-45. doi: 10.32607/actanaturae.10955.
9
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study.全球抗菌药物耐药性监测系统实施的可行性、挑战与益处：一项多中心准实验研究的结果
Antibiotics (Basel). 2022 Mar 6;11(3):348. doi: 10.3390/antibiotics11030348.
10
Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis.导致全球抗菌药物耐药性的人类学和社会经济学因素：单变量和多变量分析。
Lancet Planet Health. 2018 Sep;2(9):e398-e405. doi: 10.1016/S2542-5196(18)30186-4.
本文引用的文献
1
Challenges and shortcomings of antibacterial discovery projects.抗菌药物发现项目的挑战与不足
Clin Microbiol Infect. 2023 May;29(5):610-615. doi: 10.1016/j.cmi.2022.11.027. Epub 2022 Dec 8.
2
Antibiotic therapy for pan-drug-resistant infections.针对泛耐药感染的抗生素治疗。
Infez Med. 2022 Dec 1;30(4):525-531. doi: 10.53854/liim-3004-6. eCollection 2022.
3
Carbapenem resistance: overview of the problem and future perspectives.碳青霉烯类耐药性：问题概述与未来展望
Ther Adv Infect Dis. 2016 Feb;3(1):15-21. doi: 10.1177/2049936115621709.
4
Reviving old antibiotics.复兴旧抗生素。
J Antimicrob Chemother. 2015 Aug;70(8):2177-81. doi: 10.1093/jac/dkv157. Epub 2015 Jun 10.
Zotero 插件